Ingredient
Bis(T-Butyl Benzoxazolyl)Thiophene
Bis(T-Butyl Benzoxazolyl)Thiophene is flagged for pregnancy, breastfeeding and general use. The concern behind the strongest flag is increases sun sensitivity and absorbed into the body.
- Bis t Butyl Benzoxazolyl Thiophene
- BBOT
- Optical Brightener 357
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Bis(T-Butyl Benzoxazolyl)Thiophene and pregnancy
Caution Advised
- Increases sun sensitivity
- Absorbed into the body
Bis(T-Butyl Benzoxazolyl)Thiophene is an optical brightener that absorbs UV light and emits visible light, creating a brightening effect. It was originally developed for industrial use in textiles and plastics but has been incorporated into some cosmetic products. While no specific teratogenic studies exist for this compound, concerns arise from its chemical structure and known sensitization properties. The SCCS has raised questions about this ingredient's safety in cosmetics due to potential for skin penetration and allergic reactions. During pregnancy, skin can become more sensitive and reactive, potentially increasing susceptibility to sensitization. Additionally, the photosensitizing properties could be problematic during pregnancy when melasma and hyperpigmentation risks are already elevated. The EU has placed restrictions on this ingredient in cosmetics due to SCCS safety concerns, though it has not issued an absolute pregnancy prohibition. Many dermatologists recommend that pregnant women avoid optical brighteners and photosensitizing agents as a precautionary measure, particularly given the availability of safer alternatives for brightening effects. Women who prefer cautious approaches during pregnancy may choose to avoid this ingredient.
Bis(T-Butyl Benzoxazolyl)Thiophene and breastfeeding
Caution Advised
- Increases sun sensitivity
This optical brightener functions by absorbing UV wavelengths and re-emitting visible light, creating an appearance-enhancing effect in cosmetic products. The primary concern during breastfeeding relates to sensitization risk rather than milk transfer. The SCCS has documented allergic contact dermatitis cases associated with this ingredient. While systemic absorption data is limited, the photosensitizing properties could increase skin reactivity, which may be uncomfortable for breastfeeding mothers whose skin is already experiencing hormonal changes. If applied near the breast area, there's theoretical concern about infant contact exposure. Given the SCCS safety questions and availability of safer brightening alternatives, many dermatologists suggest breastfeeding mothers consider alternative products, particularly for leave-on formulations. The risk appears more related to skin sensitivity than milk contamination, but caution is warranted with ingredients under regulatory scrutiny.
Bis(T-Butyl Benzoxazolyl)Thiophene and postpartum
Safe to Use
- Increases sun sensitivity
- Common allergen
When not breastfeeding, the primary concerns with this ingredient relate to skin sensitization and photosensitivity rather than systemic risks. Postpartum women not breastfeeding can use products containing this ingredient with awareness of potential photosensitization and allergic reactions. Patch testing may be advisable for those with sensitive skin or history of cosmetic allergies. Sun protection is important when using this ingredient.
Bis(T-Butyl Benzoxazolyl)Thiophene and trying to conceive
Safe to Use
- Increases sun sensitivity
This ingredient has no known effects on fertility or reproductive function. The primary concerns relate to skin sensitization rather than systemic reproductive effects. Women trying to conceive can use products with this ingredient, though some may prefer to adopt pregnancy-safe routines in advance. The photosensitizing properties warrant sun protection regardless of fertility planning.
Bis(T-Butyl Benzoxazolyl)Thiophene and PCOS
Safe to Use
This optical brightener has no hormonal activity and does not interact with pathways relevant to PCOS. The compound's structure is unrelated to hormones and shows no mechanism for affecting androgen levels, insulin sensitivity, or other PCOS-related metabolic factors. Its function is purely optical/physical. Women with PCOS can use this ingredient without hormonal concerns, though standard cautions about photosensitization and sensitization still apply regardless of PCOS status.
Bis(T-Butyl Benzoxazolyl)Thiophene and general use
Caution Advised
- Irritant
- Common allergen
- Increases sun sensitivity
An optical brightening agent that absorbs UV light and re-emits it as visible light, creating a brightening and whitening visual effect on skin or fabric. Originally used in textiles and plastics, it has been incorporated into some cosmetic formulations. The SCCS has documented concerns about this ingredient, including skin sensitization potential and cases of allergic contact dermatitis. It can increase photosensitivity, making skin more reactive to sun exposure. Studies have shown it can penetrate skin to some degree, and questions remain about its long-term safety profile in leave-on cosmetic products. Individuals with sensitive skin or history of cosmetic allergies should be particularly cautious. The EU has implemented restrictions on this ingredient in cosmetics following SCCS recommendations. While not banned outright, its use is limited and scrutinized. Many cosmetic formulators are moving away from this ingredient in favor of safer brightening alternatives. Consumers seeking optical brightening effects may prefer products using titanium dioxide, mica, or other light-reflecting minerals with established safety profiles.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Bis(T-Butyl Benzoxazolyl)Thiophene, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store